These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 34494892)

  • 1. Implications of the NADase CD38 in COVID pathophysiology.
    Zeidler JD; Kashyap S; Hogan KA; Chini EN
    Physiol Rev; 2022 Jan; 102(1):339-341. PubMed ID: 34494892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD38 in the age of COVID-19: a medical perspective.
    Horenstein AL; Faini AC; Malavasi F
    Physiol Rev; 2021 Oct; 101(4):1457-1486. PubMed ID: 33787351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NADase CD38 is induced by factors secreted from senescent cells providing a potential link between senescence and age-related cellular NAD
    Chini C; Hogan KA; Warner GM; Tarragó MG; Peclat TR; Tchkonia T; Kirkland JL; Chini E
    Biochem Biophys Res Commun; 2019 May; 513(2):486-493. PubMed ID: 30975470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD38 in Neurodegeneration and Neuroinflammation.
    Guerreiro S; Privat AL; Bressac L; Toulorge D
    Cells; 2020 Feb; 9(2):. PubMed ID: 32085567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD38 activation by monosodium urate crystals contributes to inflammatory responses in human and murine macrophages.
    Wen S; Arakawa H; Tamai I
    Biochem Biophys Res Commun; 2021 Dec; 581():6-11. PubMed ID: 34637964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD
    Chini CCS; Peclat TR; Warner GM; Kashyap S; Espindola-Netto JM; de Oliveira GC; Gomez LS; Hogan KA; Tarragó MG; Puranik AS; Agorrody G; Thompson KL; Dang K; Clarke S; Childs BG; Kanamori KS; Witte MA; Vidal P; Kirkland AL; De Cecco M; Chellappa K; McReynolds MR; Jankowski C; Tchkonia T; Kirkland JL; Sedivy JM; van Deursen JM; Baker DJ; van Schooten W; Rabinowitz JD; Baur JA; Chini EN
    Nat Metab; 2020 Nov; 2(11):1284-1304. PubMed ID: 33199925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of intracellular levels of NAD: a novel role for CD38.
    Aksoy P; White TA; Thompson M; Chini EN
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1386-92. PubMed ID: 16730329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases.
    Hogan KA; Chini CCS; Chini EN
    Front Immunol; 2019; 10():1187. PubMed ID: 31214171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of Sirt6 by CD38 promotes cell senescence and aging.
    Zhou H; Liu S; Zhang N; Fang K; Zong J; An Y; Chang X
    Aging (Albany NY); 2022 Dec; 14(23):9730-9757. PubMed ID: 36490326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered behavioral and metabolic circadian rhythms in mice with disrupted NAD+ oscillation.
    Sahar S; Nin V; Barbosa MT; Chini EN; Sassone-Corsi P
    Aging (Albany NY); 2011 Aug; 3(8):794-802. PubMed ID: 21937766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV Disease Progression: Overexpression of the Ectoenzyme CD38 as a Contributory Factor?
    Rodríguez-Alba JC; Abrego-Peredo A; Gallardo-Hernández C; Pérez-Lara J; Santiago-Cruz W; Jiang W; Espinosa E
    Bioessays; 2019 Jan; 41(1):e1800128. PubMed ID: 30537007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism.
    Camacho-Pereira J; Tarragó MG; Chini CCS; Nin V; Escande C; Warner GM; Puranik AS; Schoon RA; Reid JM; Galina A; Chini EN
    Cell Metab; 2016 Jun; 23(6):1127-1139. PubMed ID: 27304511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.
    Chini EN; Chini CCS; Espindola Netto JM; de Oliveira GC; van Schooten W
    Trends Pharmacol Sci; 2018 Apr; 39(4):424-436. PubMed ID: 29482842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAD and the aging process: Role in life, death and everything in between.
    Chini CCS; Tarragó MG; Chini EN
    Mol Cell Endocrinol; 2017 Nov; 455():62-74. PubMed ID: 27825999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD38-NAD
    Chatterjee S; Chakraborty P; Mehrotra S
    Aging (Albany NY); 2019 Oct; 11(20):8743-8744. PubMed ID: 31645480
    [No Abstract]   [Full Text] [Related]  

  • 16. The CD38 glycohydrolase and the NAD sink: implications for pathological conditions.
    Zeidler JD; Hogan KA; Agorrody G; Peclat TR; Kashyap S; Kanamori KS; Gomez LS; Mazdeh DZ; Warner GM; Thompson KL; Chini CCS; Chini EN
    Am J Physiol Cell Physiol; 2022 Mar; 322(3):C521-C545. PubMed ID: 35138178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD38: A Potential Therapeutic Target in Cardiovascular Disease.
    Zuo W; Liu N; Zeng Y; Liu Y; Li B; Wu K; Xiao Y; Liu Q
    Cardiovasc Drugs Ther; 2021 Aug; 35(4):815-828. PubMed ID: 32472237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.
    Chini EN
    Curr Pharm Des; 2009; 15(1):57-63. PubMed ID: 19149603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD38 inhibitor 78c increases mice lifespan and healthspan in a model of chronological aging.
    Peclat TR; Thompson KL; Warner GM; Chini CCS; Tarragó MG; Mazdeh DZ; Zhang C; Zavala-Solorio J; Kolumam G; Liang Wong Y; Cohen RL; Chini EN
    Aging Cell; 2022 Apr; 21(4):e13589. PubMed ID: 35263032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD
    Chmielewski JP; Bowlby SC; Wheeler FB; Shi L; Sui G; Davis AL; Howard TD; D'Agostino RB; Miller LD; Sirintrapun SJ; Cramer SD; Kridel SJ
    Mol Cancer Res; 2018 Nov; 16(11):1687-1700. PubMed ID: 30076241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.